4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
10.70
-0.49 (-4.38%)
At close: Dec 5, 2025, 4:00 PM EST
10.91
+0.21 (1.96%)
After-hours: Dec 5, 2025, 7:24 PM EST
4D Molecular Therapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$30.33
Upside
+183.46%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $26 → $32 | Buy | Maintains | $26 → $32 | +199.07% | Nov 11, 2025 |
| Barclays | Barclays | Buy Maintains $38 → $33 | Buy | Maintains | $38 → $33 | +208.41% | Nov 11, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 → $26 | Strong Buy | Maintains | $25 → $26 | +142.99% | Nov 11, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $26 | Buy | Reiterates | $26 | +142.99% | Oct 21, 2025 |
| Roth Capital | Roth Capital | Strong Buy Maintains $44 → $38 | Strong Buy | Maintains | $44 → $38 | +255.14% | Aug 12, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +133.64% | Aug 12, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +133.64% | Aug 1, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +133.64% | Jul 3, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $28 → $25 | Strong Buy | Maintains | $28 → $25 | +133.64% | May 9, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $51 → $44 | Strong Buy | Maintains | $51 → $44 | +311.21% | May 9, 2025 |
| Barclays | Barclays | Buy Maintains $45 → $38 | Buy | Maintains | $45 → $38 | +255.14% | May 9, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $42 → $40 | Strong Buy | Maintains | $42 → $40 | +273.83% | Mar 10, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $30 → $28 | Strong Buy | Maintains | $30 → $28 | +161.68% | Mar 4, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $39 → $35 | Buy | Maintains | $39 → $35 | +227.10% | Mar 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +236.45% | Mar 3, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $39 → $30 | Strong Buy | Maintains | $39 → $30 | +180.37% | Feb 11, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.